SureTrader Advertisement SureTrader
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

Yep its posted:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DAD2 Member Profile
 
Followed By 65
Posts 5,085
Boards Moderated 0
Alias Born 03/11/09
160x600 placeholder
Compugen First Quarter 2016 Conference Call and Webcast Scheduled for Tuesday, May 10, 2016 at 10:00 AM ET "PR Newswire (US)" - 4/27/2016 7:15:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 4/20/2016 7:13:20 AM
Compugen Achieves Preclinical Milestone in Cancer Immunotherapy Collaboration With Bayer "PR Newswire (US)" - 4/18/2016 7:14:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 4/18/2016 7:08:15 AM
Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc. "PR Newswire (US)" - 4/6/2016 7:00:00 AM
Compugen to Present at the Jefferies Immuno-Oncology Summit in Boston "PR Newswire (US)" - 3/28/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 3/8/2016 7:01:58 AM
Compugen Presents Results for CGEN-15029 Immuno-Oncology Therapeutic Program "PR Newswire (US)" - 2/29/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/9/2016 7:11:29 AM
Compugen Ltd. Reports Fourth Quarter and Calendar 2015 Results "PR Newswire (US)" - 2/9/2016 7:09:00 AM
Compugen Fourth Quarter and Yearend 2015 Conference Call Scheduled for Tuesday, February 9, 2016 at 10:00 AM EST "PR Newswire (US)" - 1/26/2016 7:00:00 AM
Compugen Achieves Third Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer "Business Wire" - 12/11/2015 9:06:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/11/2015 8:31:41 AM
Compugen to Present at the Oppenheimer Healthcare Conference in New York "Business Wire" - 11/24/2015 7:00:00 AM
Compugen to Present at Jefferies 2015 Global Healthcare Conference in London "Business Wire" - 11/12/2015 7:00:00 AM
Compugen Presents Translational Study Results Supporting CGEN-15001 for the Treatment of Rheumatoid Arthritis "Business Wire" - 11/9/2015 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/3/2015 8:02:40 AM
Compugen Ltd. Reports 3rd Quarter 2015 Financial Results "Business Wire" - 11/3/2015 7:00:00 AM
Compugen Third Quarter 2015 Conference Call Scheduled for Tuesday, November 3, 2015 at 10:00 AM ET "Business Wire" - 10/27/2015 7:52:00 AM
Compugen Discloses Antibody Drug Conjugate Program Results at the World ADC Summit in San Diego "Business Wire" - 10/19/2015 7:00:00 AM
Compugen Discloses New Results Supporting CGEN-15052 as Novel Immune Checkpoint Target Candidate for Treatment of Cancer "Business Wire" - 9/16/2015 7:00:00 AM
Compugen to Present at Upcoming Immuno-Oncology and Rheumatology Conferences "Business Wire" - 9/9/2015 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/4/2015 7:17:55 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/4/2015 7:08:19 AM
Compugen Ltd. Reports 2nd Quarter 2015 Financial Results "Business Wire" - 8/4/2015 7:01:00 AM
DAD2   Tuesday, 02/07/12 07:23:17 AM
Re: Penny Roger$ post# 111
Post # of 146 
Yep its posted:

Zero revenues in the 4th quarter and the net loss for the 4th quarter was $4.4 million.

Might pull back slightly imo.

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist